Webinar

New study finds favourable impact of Bifidobacterium, BB-12® on infants with excessive crying and fussing

Format: External webinar | Document type: Webinar

New study finds favourable impact of Bifidobacterium, BB-12® on infants with excessive crying and fussing

Related categories: Dairy-based ingredients, Dosage forms & delivery formats, Probiotics and prebiotics, Vitamins & premixes

Excessive crying and fussing has become one of the most common reasons parents consult a health care professional during the first three months of their baby’s life. While one in four healthy infants have this experience, the exact cause is unknown. 
A recently published scientific study includes 192 breastfed Chinese infants (≤12 weeks) who cried excessively. Participants received supplementation of the BB-12® probiotic strain or placebo for 21-days. At the conclusion, the BB-12® strain not only reduced the duration of excessive crying and fussing, it also limited crying time, improved sleep and positively impacted the health-related quality of life of parents and caregivers. 
Join us as we show you the science behind Bifidobacterium, BB-12® the world’s most documented Bifidobacterium, offered exclusively by Chr. Hansen.

Watch Now

Speakers

Daniel Daniel Hovel Hansen Head of Infant & Women’s Health
Chr. Hansen

Christian Ulrich Knap Christian Ulrich Knap Commercial Development Manager – Infant & Women’s Health
Chr. Hansen – Human Health

Mehdi Sadaghian, Ph.D Mehdi Sadaghian Ph.D Scientific Advisor
Chr. Hansen – Human Health

Adam Baker, Ph.D Adam Baker Ph.D Science Director Human Health
Chr. Hansen – Human Health